Hudson, M.P., Armstrong, P.W., O'Neill, W.W., Stebbins, A.L., Weaver, W.D., Widimsky, P., Aylward, P.E., Ruzyllo, W., Holmes Jr, D.R., Mahaffey, K., et al., 2011. Mortality Implications of Primary Percutaneous Coronary Intervention Treatment Delays: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction Trial. Circulation: Cardiovascular Quality and Outcomes, 4(2), 183-192.

Ben-Gal, Y., Moses, J.W., Mehran, R., Lansky, A.J., Weisz, G., Nikolsky, E., Argenziano, M., Williams, M., Colombo, A., Aylward, P.E., et al., 2010. Surgical Versus Percutaneous Revascularization for Multivessel Disease in Patients With Acute Coronary Syndromes: Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial. JACC: Cardiovascular Interventions, 3(10), 1059-1067.

Cohen, M., Levine, G.N., Pieper, K.S., Lan, L., Antman, E., Aylward, P.E., White, H.D., Kleiman, N.S., Califf, R.M., & Mahaffey, K., 2010. Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: A subgroup analysis from the SYNERGY trial. Catheterization and Cardiovascular Interventions, 75(6), 928-935.

Wong, C., Gao, W., Stewart, R.A., French, J.K., Aylward, P.E., Benatar, J., & White, H.D., 2010. Prognostic Value of Lead V1 ST Elevation During Acute Inferior Myocardial Infarction. Circulation, 122(5), 463-469.

James, S., Budaj, A., Aylward, P.E., Buck, K.K., Cannon, C.P., Cornel, J.H., Harrington, R.A., horrow, J., Katus, H., Keltai, M., et al., 2010. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation, 122(11), 1056-1067.

Mahaffey, K., Tonev, S.T., Spinler, S., Levine, G.N., Gallo, R., Ducas, J., Goodman, S., Antman, E., Becker, R.C., Langer, A., et al., 2010. Obesity in patients with non-ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial. International Journal of Cardiology, 139(2), 123-133.

Simes, R.J., O'Connell, R.L., Aylward, P.E., Varshavsky, S., Diaz, R., Wilcox, R.G., Armstrong, P.W., Granger, C.B., French, J.K., Van De Werf, F., et al., 2010. Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. American Heart Journal, 159(6), 988-997.

White, H.D., Aylward, P.E., Gallo, R., Bode, C., Steg, G., Steinhubl, S.R., & Montalescot, G., 2010. Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial. American Heart Journal, 159(1), 110-116.

Behan, M.W., Chew, D.P., & Aylward, P.E., 2010. The role of antiplatelet therapy in the secondary prevention of coronary artery disease. Current Opinion in Cardiology, 25(4), 321-328.

Huber, K., Holmes Jr, D.R., van't Hof, A.W., Montalescot, G., Aylward, P.E., Betriu, A., Widimsky, P., Westerhout, C.M., Granger, C.B., & Armstrong, P.W., 2010. Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial. European Heart Journal, 31(14), 1708-1716.

Hudson, M.P., Armstrong, P.W., O'Neill, W.W., Stebbins, A.L., Weaver, W.D., Widimsky, P., Aylward, P.E., Ruzyllo, W., Holmes Jr, D.R., Mahaffey, K., et al., 2011. Mortality Implications of Primary Percutaneous Coronary Intervention Treatment Delays: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction Trial. Circulation: Cardiovascular Quality and Outcomes, 4(2), 183-192.

Behan, M.W., Chew, D.P., & Aylward, P.E., 2010. The role of antiplatelet therapy in the secondary prevention of coronary artery disease. Current Opinion in Cardiology, 25(4), 321-328.

Wong, C., Gao, W., Stewart, R.A., French, J.K., Aylward, P.E., Benatar, J., & White, H.D., 2010. Prognostic Value of Lead V1 ST Elevation During Acute Inferior Myocardial Infarction. Circulation, 122(5), 463-469.

Wong, C., Gao, W., Stewart, R.A., Benatar, J., French, J.K., Aylward, P.E., & White, H.D., 2010. aVR ST elevation: an important but neglected sign in ST elevation acute myocardial infarction. European Heart Journal, 31(15), 1845-1853.

White, H.D., Aylward, P.E., Gallo, R., Bode, C., Steg, G., Steinhubl, S.R., & Montalescot, G., 2010. Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial. American Heart Journal, 159(1), 110-116.

Ben-Gal, Y., Moses, J.W., Mehran, R., Lansky, A.J., Weisz, G., Nikolsky, E., Argenziano, M., Williams, M., Colombo, A., Aylward, P.E., et al., 2010. Surgical Versus Percutaneous Revascularization for Multivessel Disease in Patients With Acute Coronary Syndromes: Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial. JACC: Cardiovascular Interventions, 3(10), 1059-1067.

Cohen, M., Levine, G.N., Pieper, K.S., Lan, L., Antman, E., Aylward, P.E., White, H.D., Kleiman, N.S., Califf, R.M., & Mahaffey, K., 2010. Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: A subgroup analysis from the SYNERGY trial. Catheterization and Cardiovascular Interventions, 75(6), 928-935.

Huber, K., Holmes Jr, D.R., van't Hof, A.W., Montalescot, G., Aylward, P.E., Betriu, A., Widimsky, P., Westerhout, C.M., Granger, C.B., & Armstrong, P.W., 2010. Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial. European Heart Journal, 31(14), 1708-1716.

James, S., Budaj, A., Aylward, P.E., Buck, K.K., Cannon, C.P., Cornel, J.H., Harrington, R.A., horrow, J., Katus, H., Keltai, M., et al., 2010. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation, 122(11), 1056-1067.

Mahaffey, K., Tonev, S.T., Spinler, S., Levine, G.N., Gallo, R., Ducas, J., Goodman, S., Antman, E., Becker, R.C., Langer, A., et al., 2010. Obesity in patients with non-ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial. International Journal of Cardiology, 139(2), 123-133.

Simes, R.J., O'Connell, R.L., Aylward, P.E., Varshavsky, S., Diaz, R., Wilcox, R.G., Armstrong, P.W., Granger, C.B., French, J.K., Van De Werf, F., et al., 2010. Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. American Heart Journal, 159(6), 988-997.

White, H.D., Gallo, R., Cohen, M., Steg, G., Aylward, P.E., Bode, C., Steinhubl, S.R., & Montalescot, G., 2009. The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: Results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial. American Heart Journal, 157(1), 125-131.

Lehman, S., Baker, R.A., Aylward, P.E., Knight, J.L., & Chew, D.P., 2009. Outcomes of cardiac surgery in Indigenous Australians. Medical Journal of Australia, 190(10), 588-593.

Gibson, C.M., Pride, Y.B., Aylward, P.E., Col, J., Goodman, S., Gulba, D.C., Bergovec, M., Kunadian, V., Zorkun, C., Buros, J.L., et al., 2009. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis. Journal of Thrombosis and Thrombolysis, 27(1), 11-17.

Wong, C.K., Gao, W., Stewart, R.A., French, J.K., Aylward, P.E., & White, H.D., 2009. Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: results from the Hirulog and Early Reperfusion or Occlusion-2 trial. Heart, 95(4), 276-282.

Aroney, C.N., Aylward, P.E., Chew, D.P., Huang, N., Kelly, A., White, H.D., & Wison, M., 2008. 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes 2006. Medical Journal of Australia, 188(5), 302-303.

Piccini, J.P., Hranitzky, P.M., Kilaru, R., Rouleau, J., White, H.D., Aylward, P.E., Van De Werf, F., Solomon, S.D., Califf, R.M., & Velazquez, E.J., 2008. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction. American Journal of Cardiology, 102(11), 1427-1432.

Perry, R., Joseph, M., De Pasquale, C.G., Chew, D.P., Yiu, D., Aylward, P.E., & Mangoni, A.A., 2008. High-resolution transthoracic echocardiography of the left anterior descending coronary artery: a novel noninvasive assessment of coronary vasoreactivity. Journal of The American Society of Echocardiography, 21(2), 134-138.

Perry, R., De Pasquale, C.G., Chew, D.P., Brown, L., Aylward, P.E., & Joseph, M., 2008. Changes in left anterior descending coronary artery wall thickness detected by high resolution transthoracic echocardiography. American Journal of Cardiology, 101(7), 937-940.

Astley, C., Chew, D.P., Aylward, P.E., Molloy, D.A., & De Pasquale, C.G., 2008. A randomised study of three different informational aids prior to coronary angiography, measuring patient recall, satisfaction and anxiety. Heart, Lung and Circulation, 17(1), 25-32.

Brener, S.J., Moliterno, D.J., Aylward, P.E., van't Hof, A.W., Ruzyllo, W., O'Neill, W.W., Hamm, C.W., Westerhout, C.M., Granger, C.B., & Armstrong, P., 2008. Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI Angiographic Study. European Heart Journal, 29(9), 1127-1135.

Chew, D.P., Huang, Z., Pieper, K.S., White, H.D., Mahaffey, K., Ferguson, J.J., Califf, R.M., & Aylward, P.E., 2008. Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy. American Heart Journal, 155(2), 239-244.

Chew, D.P., Mahaffey, K., White, H.D., Huang, Z., Hoekstra, J., Ferguson, J.J., Califf, R.M., & Aylward, P.E., 2008. Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict. American Heart Journal, 155(5), 841-847.

Leung, S., Gallup, D., Mahaffey, K., Cohen, M., Antman, E., Goodman, S., Harrington, R.A., Langer, A., Aylward, P.E., Ferguson, J.J., et al., 2008. Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome. American Heart Journal, 156(1), 177-184.

Lopes, R.D., Alexander, K.P., Marcucci, g., White, H.D., Spinler, S., Col, J., Aylward, P.E., Califf, R.M., & Mahaffey, K., 2008. Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial. European Heart Journal, 29(15), 1827-1833.

Mahaffey, K., Yang, Q., Pieper, K.S., Antman, E., White, H.D., Goodman, S., Cohen, M., Kleiman, N.S., Langer, A., Aylward, P.E., et al., 2008. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. Journal of General Internal Medicine, 23(3), 310-316.

Montalescot, G., Cohen, M., Salette3, G., Desmet, W., Macaya, C., Aylward, P.E., Steg, G., White, H.D., Gallo, R., & Steinhubl, S.R., 2008. Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial. European Heart Journal, 29(4), 462-471.

Edmond, J.J., French, J.K., Aylward, P.E., Wong, C.K., Stewart, R.A., Williams, B.F., De Pasquale, C.G., O'Connell, R.L., Van den Berg, K., Van De Werf, F., et al., 2007. Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2. European Heart Journal, 28(12), 1418-1424.

Tricoci, P., Lokhnygina, Y., Berdan, L., Steinhubl, S.R., Gulba, D.C., White, H.D., Kleiman, N.S., Aylward, P.E., Langer, A., Califf, R.M., et al., 2007. Time to coronary angiography and outcomes among patients with high-risk non-ST-segment-elevation acute coronary syndromes: results from the SYNERGY trial. Circulation, 116(23), 2669-2677.

Miller, C.D., Banerjee, A., Mahaffey, K., Kontos, M.C., Fermann, G., Pollack, C.V., Antman, E., Aylward, P.E., Goodman, S., Santos, R., et al., 2007. Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial. European Heart Journal, 28(9), 1079-1084.

Wong, C.K., Newby, L.K., Bhapker, M.V., Aylward, P.E., Pfisterer, M., Alexander, K.P., Armstrong, P., Hochman, J., Van De Werf, F., Califf, R.M., et al., 2007. Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: Insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials. American Heart Journal, 154(2), 313-321.

Chew, D.P., Astley, C., Molloy, D.A., Vaile, J., De Pasquale, C.G., & Aylward, P.E., 2006. Morbidity, mortality and economic burden of renal impairment in cardiac intensive care. Internal Medicine Journal, 36(3), 185-192.

Edmond, J.J., French, J.K., Stewart, R.A., Aylward, P.E., De Pasquale, C.G., Williams, B.F., O'Connell, R.L., Simes, R., & White, H.D., 2006. Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques. American Journal of Cardiology, 97(7), 947-951.

Hochman, J., Sleeper, L., Webb, J., Dzavik, V., Buller, C.E., Aylward, P.E., Col, J., & White, H.D., 2006. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA-Journal of The American Medical Association, 295(21), 2511-2515.

Kauf, T., Velazquez, E.J., Crosslin, D.R., Weaver, W.D., Diaz, R., Granger, C.B., McMurray, J.J., Rouleau, J., Aylward, P.E., White, H.D., et al., 2006. The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. American Heart Journal, 151(1), 206-212.

Kaul, P., Chang, W., Lincoff, A.M., Aylward, P.E., Betriu, A., Bode, C., Califf, R.M., Ohman, E.M., Guetta, V., Steg, G., et al., 2006. Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial. European Heart Journal, 27(10), 1198-1206.

Montalescot, G., White, H.D., Gallo, R., Cohen, M., Steg, G., Aylward, P.E., Bode, C., Chiariello, M., King, S., Harrington, R.A., et al., 2006. Enoxaparin versus unfractioned heparin in elective percutaneous coronary intervention. New England Journal of Medicine, 355(10), 1006-1017.

Perry, R., De Pasquale, C.G., Chew, D.P., Aylward, P.E., & Joseph, M., 2006. QRS duration alone misses cardiac dyssynchrony in a substantial proportion of patients with chronic heath failure. Journal of The American Society of Echocardiography, 19(10), 1257-1263.

Stone, G.W., McLaurin, B.T., Cox, D.A., Bertrand, M.E., Lincoff, A.M., Moses, J.W., White, H.D., Pocock, S.J., Ware, J.H., Feit, F., et al., 2006. Bivalirudin for patients with acute coronary syndromes. New England Journal of Medicine, 355(21), 2203-2217.

White, H.D., Kleiman, N.S., Mahaffey, K., Lokhnygina, Y., Pieper, K.S., Chiswell, K., Cohen, M., Harrington, R.A., Chew, D.P., Petersen, J.L., et al., 2006. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the SYNERGY trial. American Heart Journal, 152(6), 1042-1050.

Wong, C.K., Gao, W., Stewart, R.A., van Pelt, N., French, J.K., Aylward, P.E., & White, H.D., 2006. Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy. Circulation, 114(8), 783-789.

Astley, C., Molloy, D.A., Kangarahan, N., Aylward, P.E., Vaile, J., & Chew, D.P., 2005. Incremental Cost of Invasive Management In the Australian Setting. Heart, Lung and Circulation, 14, 211-211.

Chew, D.P., Aylward, P.E., & White, H.D., 2005. Facilitated percutaneous coronary intervention: Is this strategy ready for implementation?. Current Cardiology Reports, 7(4), 235-241.

D'Souza, K., Mooney, D., Russell, A.E., MacIsaac, A., Aylward, P.E., & Prior, D., 2005. Abnormal septal motion affects early diastolic velocities at the septal and lateral mitral annulus, and impacts on estimation of the pulmonary capillary wedge pressure. Journal of The American Society of Echocardiography, 18(5), 445-453.

De Pasquale, C.G., Arnolda, L.F., Doyle, I.R., Aylward, P.E., Russell, A.E., & Bersten, A.D., 2005. Circulating surfactant protein-B levels increase acutely in response to exercise-induced left ventricular dysfunction. Clinical and Experimental Pharmacology and Physiology, 32(8), 622-627.

Frazier, C.G., Shah, S.H., Armstrong, P., Bhapkar, M.V., McGuire, D.K., Sadowski, Z., Kristinsson, A., Aylward, P.E., Klein, W.W., Weaver, W.D., et al., 2005. Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: Observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) RCTs. American Heart Journal, 150(6), 1260-1267.

Mahaffey, K., Cohen, M., Garg, J., Antman, E., Kleiman, N.S., Goodman, S., Berdan, L., Reist, C.J., Langer, A., White, H.D., et al., 2005. High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. JAMA-Journal of The American Medical Association, 294(20), 2594-2600.

White, H., Assmann, S., Sanborn, T., Jacobs, A., Webb, J., Sleeper, L., Wong, C., Stewart, J., Aylward, P.E., Wong, S., et al., 2005. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock - results from the should we emergently revascularize occluded coronaries for cardiogenic shock. Circulation, 112(13), 1992-2001.

White, H.D., Aylward, P.E., Huang, Z., Dalby, A.J., Weaver, W.D., Barvik, S., Marin-Neto, J.A., Murin, J., Nordlander, R., van Gilst, W.H., et al., 2005. Mortality and mobidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the VALIANT trial. Circulation, 112(22), 3391-3399.

De Pasquale, C.G., Arnolda, L.F., Aylward, P.E., Chew, D.P., & Bersten, A.D., 2004. Plasma surfactant protein-B: a novel biomarker in chronic heart failure. Circulation, 110(9), 1091-1096.

Kaul, P., Newby, L.K., Fu, Y., Mark, D.B., Califf, R.M., Topol, E.J., Aylward, P.E., Granger, C., Van De Werf, F., & Armstrong, P., 2004. International differences in evolution of early discharge after acute myocardial infarction. Lancet, 363(9408), 511-517.

De Pasquale, C.G., Arnolda, L.F., Doyle, I.R., Grant, R.L., Aylward, P.E., & Bersten, A.D., 2003. Prolonged alveolocapillary barrier damage after acute cardiogenic pulmonary edema. Critical Care Medicine, 31(4), 1060-1067.

De Pasquale, C.G., Bersten, A.D., Doyle, I.R., Aylward, P.E., & Arnolda, L.F., 2003. Infarct-induced chronic heart failure increases bidirectional protein movement across the alveolocapillary barrier. American Journal of Physiology-Heart and Circulatory Physiology, 284(6), H2136-H2145.

Newby, L.K., Kristinsson, A., Bhapkar, M.V., Aylward, P.E., Dimas, A.P., Klein, W.W., McGuire, D.K., Moliterno, D.J., Verheugt, F.W., Weaver, W.D., et al., 2002. Early statin initiation and outcomes in patients with acute coronary syndromes. JAMA-Journal of The American Medical Association, 287(23), 3087-3095.

Robson, R., White, H.D., Aylward, P.E., & Frampton, C., 2002. Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender. Clinical Pharmacology and Therapeutics, 71(6), 433-439.

Wong, C.K., French, J., Andrews, J., Frey, M.J., Adgey, A.A., Aylward, P.E., & White, H.D., 2002. Usefulness of the presenting electrocardiogram in predicting myocardial salvage with thrombolytic therapy in patients with a first acute myocardial infarction. European Heart Journal, 23(5), 399-404.

Wong, C.K., French, J., Krucoff, M.W., Gao, W., Aylward, P.E., & White, H.D., 2002. Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion. European Heart Journal, 23(18), 1449-1455.

Aroney, C.N. & Aylward, P.E., 2007. Guidelines for the management of acute coronary syndromes 2006. MJA Medical Journal of Australia, 187(6), 372-372.

Astley, C., Molloy, D.A., Vaile, J., Aylward, P.E., & Chew, D.P., 2006. The relative contribution of risk stratification components to 6-month mortality in ACS. Heart, Lung and Circulation, 15(Suppl. 1), S86-S86.

Molaee, P., Lehman, S., Bridgman, C., Astley, C., Tideman, P.A., Aylward, P.E., De Pasquale, C.G., & Chew, D.P., 2006. The poor man's multi-marker approach to risk stratification in acute coronary syndromes. Heart, Lung and Circulation, 15(Suppl. 1), S91-S92.

Lehman, S., Aylward, P.E., Astley, C., Bridgman, C., Molaee, P., Vaile, J., Worthley, S.G., & Chew, D.P., 2006. The effect of cardiac arrest in hospitalised patients on mortality in an Australian cohort. Heart, Lung and Circulation, 15(Suppl. 1), S88-S88.

Huynh, L., Astley, C., De Pasquale, C.G., Vaile, J., Aylward, P.E., & Chew, D.P., 2006. Patient factors and the usage of acute coronary syndrome clinical guidelines. Heart, Lung and Circulation, 15(Suppl. 1), S88-S89.

Evans, G.D., Astley, C., Molloy, D.A., Tideman, P.A., Aylward, P.E., Chew, D.P., Kangaharan, N., & Worthley, S.G., 2005. Renal impairment is not a justification for conservative management in ACS: a matched analysis. Heart, Lung and Circulation, 14(Suppl. 1), S73-S73.

Astley, C., Chew, D.P., Aylward, P.E., Molloy, D.A., & De Pasquale, C.G., 2005. Audiovisual information delivery does not improve the quality of informed consent in coronary angiography. Heart, Lung and Circulation, 14(Suppl. 1), S2-S2.

Astley, C., Molloy, D.A., Kangaharan, N., Aylward, P.E., Vaile, J., & Chew, D.P., 2005. Invasive management does not appear to be associated with increased cost in the Australian setting. Heart, Lung and Circulation, 14(Suppl. 1), S57-S57.

Chew, D.P., Kangaharan, N., Evans, G.D., Astley, C., Molloy, D.A., Vaile, J., De Pasquale, C.G., & Aylward, P.E., 2005. The morbidity, mortality and economic burden of renal impairment in cardiac intensive care. Heart, Lung and Circulation, 14(Suppl. 1), S71-S71.

Astley, C., Chew, D.P., Aylward, P.E., & De Pasquale, C.G., 2004. The importance of demographics in optimising informed consent for coronary angiography. Heart, Lung and Circulation, 13(suppl2), s106-s106.

Schrale, R.G., Astley, C., De Pasquale, C.G., Aylward, P.E., & Chew, D.P., 2004. Bleeding complications are strongly associated with in-hospital death and myocardial infarction in acute coronary syndromes. Heart, Lung and Circulation, 13(Suppl. 2), S104-S104.

Astley, C., Chew, D.P., Aylward, P.E., & De Pasquale, C.G., 2004. Informed consent process for coronary angiography: a pilot study to assess comprehension, recall, satisfaction and anxiety. Heart, Lung and Circulation, 13(Suppl. 2), S105-S106.

Astley, C., Aylward, P.E., Hakendorf, P.H., Chew, D.P., & De Pasquale, C.G., 2004. Age Is Not Necessarily Associated With Greater Cost In Patients With Acute Myocardial Infarction. Heart, Lung and Circulation, 13(Suppl. 2), S64-S64.

De Pasquale, C.G., Arnolda, L.F., Doyle, I.R., Aylward, P.E., & Bersten, A.D., 2003. Acute cardiogenic pulmonary edema results in increased plasma tumor necrosis factor and alpha and alveolocapillary barrier damage. Heart, Lung and Circulation, 12(2), A58-A58.

De Pasquale, C.G., Arnolda, L.F., Doyle, I.R., Aylward, P.E., Russell, A.E., & Bersten, A.D., 2002. Surfactant protein-B in cardiogenic pulmonary edema: a novel and clinically relevant, peripheral marker of alveolocapillary barrier damage. Heart, Lung and Circulation, 12(2), A92-A92.

Magarey, J.A., MacDougall, C.J., Putland, C., Baum, F.E., & Aylward, P.E., 2001. Perceptions of safety and implications for social capital. 2001 A Public Health Odessey, Popular Culture, Science and Politics, Program and Abstracts, 57-57.

Aylward, P.E., Magarey, J.A., Baum, F.E., MacDougall, C.J., & Putland, C., 2001. Measuring social capital: a factor analysis. 2001 A Public Health Odessey, Popular Culture, Science and Politics, Program and Abstracts.

De Pasquale, C.G., Arnolda, L.F., Bersten, A.D., Aylward, P.E., Doyle, I.R., & Grant, R.L., 2001. Alteration in circulating surfactant protein A and B levels in acute cardiogenic pulmonary edema. Heart, Lung and Circulation.

De Pasquale, C.G., Bersten, A.D., Aylward, P.E., Doyle, I.R., Grant, R.L., & Arnolda, L.F., 2001. Alteration in circulating surfactant protein A and B levels in acute cardiogenic pulmonary edema. American Journal of Respiratory & Critical Care Medicine Supplement ATS 2001.

Doyle, I.R., Bersten, A.D., De Pasquale, C.G., Arnolda, L.F., & Aylward, P.E., 2001. Altered alveolocapillary permeability to surfactant protein-B in congestive heart failure. Circulation.

De Pasquale, C.G., Arnolda, L.F., Doyle, I.R., Aylward, P.E., & Bersten, A.D., 2003. Congestive heart failure increases bi-directional protein movement across the alveolocapillary barrier.